| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Revenue | $7.7M | +26.3% |
| Cost of Revenue | $2.2M | -7.3% |
| Gross Profit | $5.5M | +47.8% |
| R&D Expense | $4.1M | +19.2% |
| SG&A Expense | $12.9M | -4.6% |
| Operating Income | -$11.9M | +14.4% |
| Interest Expense | $79K | +53.7% |
| Net Income | -$14.5M | +23.4% |
| EPS (Basic) | -$0.07 |
| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.0M | -26.6% |
| Inventory | $1.3M | -16.7% |
| Current Assets | $2.9M | -41.6% |
| Total Assets | $9.3M | -15.3% |
| Current Liabilities | $20.0M | +163.3% |
| Total Liabilities | $62.0M | +2.4% |
| Stockholders' Equity | -$53.2M | -6.6% |
| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.3M | +23.4% |
| Capital Expenditures | $11K | -54.2% |
| Investing Cash Flow | -$13K | +83.9% |
| Financing Cash Flow | $8.6M | -34.0% |
| Free Cash Flow | -$9.4M | +23.4% |
| — |
| EPS (Diluted) | -$0.07 | — |